Steffen L.
- Country
- Denmark
- Department
- DK004
Research Overview
- Randomized, Double‑Blind, Placebo‑Controlled Trial of Long‑Acting bNAbs 10‑1074‑LS and 3BNC117‑LS with Low‑Dose Nivolumab for Durable HIV‑1 Remission during ART Interruption
- Evaluation of Tozorakimab Efficacy and Safety in Hospitalized Patients with Severe Viral Lung Infections Requiring Supplemental Oxygen: A Phase III Randomized Study
- Phase 3 Double-Blind Study of Ibuzatrelvir Versus Placebo in Non-Hospitalized Adults and Adolescents with COVID-19 at High Risk for Severe Illness
Data & Insights
Has run more than one trial at 15 of 161 partner sites.
Specializations
Respiratory Viral Infections
The investigator specializes in treating severe viral respiratory conditions, with particular emphasis on respiratory syncytial virus (RSV) and other acute viral lung infections requiring medical intervention.
- Viral Lung Infections
- Respiratory Disease Management
- Critical Care Medicine
Their clinical focus extends to patients requiring supplemental oxygen and advanced respiratory support.
Maternal-Infant Health
The investigator has developed expertise in maternal immunization and its effects on infant health, particularly focusing on preventive strategies against respiratory infections during pregnancy.
- Maternal Vaccination
- Infant Immune Response
- Pregnancy Safety Protocols
Their work encompasses monitoring both maternal immune responses and infant health outcomes.
Critical Care Interventions
The investigator focuses on advanced therapeutic approaches for patients with severe respiratory conditions, including those requiring intensive medical support.
- Oxygen Therapy Management
- Respiratory Support Systems
- Emergency Care Protocols
Their expertise includes treating patients requiring various levels of respiratory intervention.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.